Benjamin Trinité

Benjamin Trinité

New York University

H-index: 22

North America-United States

About Benjamin Trinité

Benjamin Trinité, With an exceptional h-index of 22 and a recent h-index of 19 (since 2020), a distinguished researcher at New York University, specializes in the field of Immunology, HIV, SARS-CoV-2.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2

Benjamin Trinité Information

University

Position

Postdoctoral researcher

Citations(all)

1819

Citations(since 2020)

1136

Cited By

875

hIndex(all)

22

hIndex(since 2020)

19

i10Index(all)

34

i10Index(since 2020)

30

Email

University Profile Page

Google Scholar

Benjamin Trinité Skills & Research Interests

Immunology

HIV

SARS-CoV-2

Top articles of Benjamin Trinité

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

npj Vaccines

2024/2/27

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Nature Communications

2024/2/5

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Mónica Pérez
Mónica Pérez

H-Index: 43

Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice

Journal of Translational Medicine

2024/1/3

Benjamin Trinité
Benjamin Trinité

H-Index: 13

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine

2024/4/18

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Lan Zhang
Lan Zhang

H-Index: 21

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

Medicina Clínica (English Edition)

2024/4/12

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Nature Communications

2024/3/21

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

Iscience

2023/3/17

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2

Proceedings of the National Academy of Sciences

2023/3/7

Jennifer Wilson
Jennifer Wilson

H-Index: 3

Benjamin Trinité
Benjamin Trinité

H-Index: 13

A Novel Monoclonal Antibody Targeting a Large Surface of the Receptor Binding Motif Shows Pan-neutralizing SARS-CoV-2 Activity Including BQ. 1.1 Variant

bioRxiv

2023/1/23

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Mónica Pérez
Mónica Pérez

H-Index: 43

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

Frontiers in immunology

2023/12/4

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

npj Vaccines

2023/9/29

Cyanovirin-N: A lectin that can help block the spread of COVID-19

2023/8/4

Jennifer Wilson
Jennifer Wilson

H-Index: 3

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity

International Journal of Molecular Sciences

2023/5/19

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre …

The Lancet Regional Health–Europe

2023/5/1

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization

Iscience

2023/4/21

Ignacio Blanco
Ignacio Blanco

H-Index: 5

Benjamin Trinité
Benjamin Trinité

H-Index: 13

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

npj Vaccines

2023/4/6

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors

Molecular Oncology

2023/4

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Gating strategy for the identification of anti-inflammatory effects of selected compounds

2022/1/13

Benjamin Trinité
Benjamin Trinité

H-Index: 13

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Nature Communications, 2022, vol. 13, num. 1

2022/5/11

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells

PLoS pathogens

2022/1/13

See List of Professors in Benjamin Trinité University(New York University)